nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Spironolactone—hypertension	0.387	1	CrCtD
Oxandrolone—AR—hypertension	0.221	1	CbGaD
Oxandrolone—AR—Spironolactone—hypertension	0.0914	1	CbGbCtD
Oxandrolone—Spironolactone—Eplerenone—hypertension	0.0336	0.151	CrCrCtD
Oxandrolone—Fluoxymesterone—Eplerenone—hypertension	0.0214	0.0957	CrCrCtD
Oxandrolone—Progesterone—Eplerenone—hypertension	0.0208	0.0933	CrCrCtD
Oxandrolone—Testosterone Propionate—Eplerenone—hypertension	0.0208	0.0933	CrCrCtD
Oxandrolone—Methyltestosterone—Eplerenone—hypertension	0.0203	0.0909	CrCrCtD
Oxandrolone—Fluoxymesterone—Spironolactone—hypertension	0.0186	0.0833	CrCrCtD
Oxandrolone—Progesterone—Spironolactone—hypertension	0.0181	0.0811	CrCrCtD
Oxandrolone—Testosterone Propionate—Spironolactone—hypertension	0.0181	0.0811	CrCrCtD
Oxandrolone—Testosterone—Eplerenone—hypertension	0.0181	0.081	CrCrCtD
Oxandrolone—Methyltestosterone—Spironolactone—hypertension	0.0176	0.0791	CrCrCtD
Oxandrolone—Testosterone—Spironolactone—hypertension	0.0157	0.0704	CrCrCtD
Oxandrolone—Bronchial hyperreactivity—Amlodipine—hypertension	0.00135	0.0239	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Amlodipine—hypertension	0.00123	0.0218	CcSEcCtD
Oxandrolone—Glucose tolerance decreased—Furosemide—hypertension	0.00109	0.0192	CcSEcCtD
Oxandrolone—Priapism—Prazosin—hypertension	0.00103	0.0181	CcSEcCtD
Oxandrolone—Epididymitis—Doxazosin—hypertension	0.000981	0.0173	CcSEcCtD
Oxandrolone—Priapism—Terazosin—hypertension	0.000803	0.0142	CcSEcCtD
Oxandrolone—Menstruation irregular—Spironolactone—hypertension	0.000725	0.0128	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Hydroflumethiazide—hypertension	0.00069	0.0122	CcSEcCtD
Oxandrolone—Bronchial hyperreactivity—Timolol—hypertension	0.000677	0.012	CcSEcCtD
Oxandrolone—Hepatic necrosis—Labetalol—hypertension	0.000645	0.0114	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Timolol—hypertension	0.000618	0.0109	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—GATA6—hypertension	0.000603	0.035	CbGpPWpGaD
Oxandrolone—Creatinine increased—Fenoldopam—hypertension	0.000597	0.0105	CcSEcCtD
Oxandrolone—Priapism—Doxazosin—hypertension	0.000597	0.0105	CcSEcCtD
Oxandrolone—Trilostane—HSD3B1—hypertension	0.00058	0.196	CrCbGaD
Oxandrolone—Jaundice cholestatic—Chlorothiazide—hypertension	0.000579	0.0102	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Chlorthalidone—hypertension	0.000568	0.01	CcSEcCtD
Oxandrolone—Gynaecomastia—Reserpine—hypertension	0.000527	0.0093	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—RCHY1—hypertension	0.000488	0.0284	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—LGALS13—hypertension	0.000485	0.0282	CbGpPWpGaD
Oxandrolone—Jaundice cholestatic—Benazepril—hypertension	0.000476	0.00841	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Metolazone—hypertension	0.000459	0.0081	CcSEcCtD
Oxandrolone—Gynaecomastia—Bumetanide—hypertension	0.000444	0.00784	CcSEcCtD
Oxandrolone—Gynaecomastia—Prazosin—hypertension	0.000444	0.00784	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Labetalol—hypertension	0.000427	0.00753	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—GNRH1—hypertension	0.000411	0.0239	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Mecamylamine—hypertension	0.00041	0.00724	CcSEcCtD
Oxandrolone—Gynaecomastia—Methyldopa—hypertension	0.000399	0.00705	CcSEcCtD
Oxandrolone—Hepatic necrosis—Captopril—hypertension	0.000398	0.00703	CcSEcCtD
Oxandrolone—Fluid retention—Nadolol—hypertension	0.000396	0.00699	CcSEcCtD
Oxandrolone—Trilostane—HSD3B2—hypertension	0.000392	0.132	CrCbGaD
Oxandrolone—Gynaecomastia—Amiloride—hypertension	0.000392	0.00692	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C2—hypertension	0.000392	0.0227	CbGpPWpGaD
Oxandrolone—Fluid retention—Isradipine—hypertension	0.00039	0.00688	CcSEcCtD
Oxandrolone—Blood creatinine increased—Fenoldopam—hypertension	0.000386	0.00682	CcSEcCtD
Oxandrolone—Erectile dysfunction—Bendroflumethiazide—hypertension	0.000374	0.0066	CcSEcCtD
Oxandrolone—Gynaecomastia—Isradipine—hypertension	0.000367	0.00649	CcSEcCtD
Oxandrolone—Gynaecomastia—Felodipine—hypertension	0.000361	0.00637	CcSEcCtD
Oxandrolone—Gynaecomastia—Spironolactone—hypertension	0.000359	0.00634	CcSEcCtD
Oxandrolone—Erectile dysfunction—Reserpine—hypertension	0.00034	0.00601	CcSEcCtD
Oxandrolone—Blood creatinine increased—Bumetanide—hypertension	0.000337	0.00596	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Indapamide—hypertension	0.000335	0.00592	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nebivolol—hypertension	0.00032	0.00566	CcSEcCtD
Oxandrolone—Gynaecomastia—Amlodipine—hypertension	0.000315	0.00557	CcSEcCtD
Oxandrolone—Gynaecomastia—Nisoldipine—hypertension	0.000315	0.00557	CcSEcCtD
Oxandrolone—Hepatic necrosis—Ramipril—hypertension	0.000311	0.00549	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—SRF—hypertension	0.000309	0.0179	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Candesartan—hypertension	0.000308	0.00544	CcSEcCtD
Oxandrolone—Creatinine increased—Carvedilol—hypertension	0.000306	0.00541	CcSEcCtD
Oxandrolone—Erectile dysfunction—Torasemide—hypertension	0.000302	0.00533	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—GATA4—hypertension	0.000301	0.0175	CbGpPWpGaD
Oxandrolone—Creatinine increased—Fosinopril—hypertension	0.000299	0.00529	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—CYP2C18—hypertension	0.000298	0.0173	CbGpPWpGaD
Oxandrolone—Creatinine increased—Eplerenone—hypertension	0.000298	0.00525	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Olmesartan—hypertension	0.000295	0.00521	CcSEcCtD
Oxandrolone—Necrosis—Captopril—hypertension	0.000295	0.00521	CcSEcCtD
Oxandrolone—Erectile dysfunction—Chlorothiazide—hypertension	0.000294	0.00519	CcSEcCtD
Oxandrolone—Irritability—Nadolol—hypertension	0.000289	0.0051	CcSEcCtD
Oxandrolone—Erectile dysfunction—Chlorthalidone—hypertension	0.000288	0.00509	CcSEcCtD
Oxandrolone—Haemoglobin—Fenoldopam—hypertension	0.000287	0.00507	CcSEcCtD
Oxandrolone—Erectile dysfunction—Prazosin—hypertension	0.000287	0.00506	CcSEcCtD
Oxandrolone—Haemorrhage—Fenoldopam—hypertension	0.000285	0.00504	CcSEcCtD
Oxandrolone—Blood creatinine increased—Benazepril—hypertension	0.000285	0.00503	CcSEcCtD
Oxandrolone—Irritability—Guanfacine—hypertension	0.000283	0.005	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—MYOD1—hypertension	0.000282	0.0164	CbGpPWpGaD
Oxandrolone—Irritability—Felodipine—hypertension	0.000279	0.00493	CcSEcCtD
Oxandrolone—Fluid retention—Carvedilol—hypertension	0.000277	0.00489	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Trandolapril—hypertension	0.000276	0.00487	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Enalapril—hypertension	0.000275	0.00485	CcSEcCtD
Oxandrolone—Irritability—Esmolol—hypertension	0.000272	0.00481	CcSEcCtD
Oxandrolone—Erectile dysfunction—Bepridil—hypertension	0.000271	0.00478	CcSEcCtD
Oxandrolone—Erectile dysfunction—Penbutolol—hypertension	0.000268	0.00474	CcSEcCtD
Oxandrolone—Haemoglobin—Torasemide—hypertension	0.000264	0.00466	CcSEcCtD
Oxandrolone—Gynaecomastia—Diltiazem—hypertension	0.000264	0.00465	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Captopril—hypertension	0.000263	0.00465	CcSEcCtD
Oxandrolone—Haemorrhage—Torasemide—hypertension	0.000262	0.00463	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—SERPINA1—hypertension	0.00026	0.0151	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Doxazosin—hypertension	0.000258	0.00456	CcSEcCtD
Oxandrolone—Erectile dysfunction—Methyldopa—hypertension	0.000258	0.00455	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Irbesartan—hypertension	0.000255	0.0045	CcSEcCtD
Oxandrolone—Creatinine increased—Trandolapril—hypertension	0.000255	0.00449	CcSEcCtD
Oxandrolone—Gynaecomastia—Eplerenone—hypertension	0.000253	0.00448	CcSEcCtD
Oxandrolone—Erectile dysfunction—Amiloride—hypertension	0.000253	0.00447	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Hydrochlorothiazide—hypertension	0.000253	0.00446	CcSEcCtD
Oxandrolone—Gynaecomastia—Nifedipine—hypertension	0.000252	0.00444	CcSEcCtD
Oxandrolone—Gynaecomastia—Verapamil—hypertension	0.00025	0.00442	CcSEcCtD
Oxandrolone—Erectile dysfunction—Pindolol—hypertension	0.00025	0.00441	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Furosemide—hypertension	0.000249	0.00439	CcSEcCtD
Oxandrolone—Blood creatinine increased—Eprosartan—hypertension	0.000247	0.00436	CcSEcCtD
Oxandrolone—Erectile dysfunction—Quinapril—hypertension	0.000246	0.00434	CcSEcCtD
Oxandrolone—Erectile dysfunction—Benazepril—hypertension	0.000242	0.00427	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nadolol—hypertension	0.000241	0.00425	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Losartan—hypertension	0.00024	0.00424	CcSEcCtD
Oxandrolone—Erectile dysfunction—Isradipine—hypertension	0.000237	0.00419	CcSEcCtD
Oxandrolone—Erectile dysfunction—Guanfacine—hypertension	0.000236	0.00417	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nicardipine—hypertension	0.000235	0.00416	CcSEcCtD
Oxandrolone—Erectile dysfunction—Metolazone—hypertension	0.000233	0.00411	CcSEcCtD
Oxandrolone—Erectile dysfunction—Felodipine—hypertension	0.000233	0.00411	CcSEcCtD
Oxandrolone—Erectile dysfunction—Spironolactone—hypertension	0.000232	0.0041	CcSEcCtD
Oxandrolone—Haemoglobin—Candesartan—hypertension	0.000228	0.00403	CcSEcCtD
Oxandrolone—Haemorrhage—Candesartan—hypertension	0.000227	0.00401	CcSEcCtD
Oxandrolone—Erectile dysfunction—Terazosin—hypertension	0.000224	0.00396	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR2—hypertension	0.000223	0.013	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Clonidine—hypertension	0.000222	0.00393	CcSEcCtD
Oxandrolone—Haemoglobin—Amiloride—hypertension	0.000221	0.00391	CcSEcCtD
Oxandrolone—Haemorrhage—Amiloride—hypertension	0.00022	0.00389	CcSEcCtD
Oxandrolone—Erectile dysfunction—Acebutolol—hypertension	0.000219	0.00386	CcSEcCtD
Oxandrolone—Erectile dysfunction—Labetalol—hypertension	0.000217	0.00383	CcSEcCtD
Oxandrolone—Gynaecomastia—Enalapril—hypertension	0.000216	0.00381	CcSEcCtD
Oxandrolone—Fluid retention—Perindopril—hypertension	0.000213	0.00377	CcSEcCtD
Oxandrolone—Irritability—Propranolol—hypertension	0.000211	0.00372	CcSEcCtD
Oxandrolone—Oedema—Reserpine—hypertension	0.00021	0.00371	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—PTK2—hypertension	0.000208	0.0121	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Captopril—hypertension	0.000207	0.00366	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Ramipril—hypertension	0.000206	0.00363	CcSEcCtD
Oxandrolone—Irritability—Indapamide—hypertension	0.000204	0.0036	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nisoldipine—hypertension	0.000204	0.0036	CcSEcCtD
Oxandrolone—Erectile dysfunction—Amlodipine—hypertension	0.000204	0.0036	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SMAD6—hypertension	0.000202	0.0117	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Carvedilol—hypertension	0.000198	0.0035	CcSEcCtD
Oxandrolone—Blood creatinine increased—Fosinopril—hypertension	0.000194	0.00342	CcSEcCtD
Oxandrolone—Blood creatinine increased—Eplerenone—hypertension	0.000193	0.0034	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—GCG—hypertension	0.000192	0.0111	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Metoprolol—hypertension	0.000191	0.00338	CcSEcCtD
Oxandrolone—Creatinine increased—Ramipril—hypertension	0.00019	0.00335	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—KCNQ1—hypertension	0.000188	0.0109	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—KCNJ8—hypertension	0.000188	0.0109	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—ROCK2—hypertension	0.000188	0.0109	CbGpPWpGaD
Oxandrolone—Jaundice cholestatic—Lisinopril—hypertension	0.000187	0.00329	CcSEcCtD
Oxandrolone—Oedema—Torasemide—hypertension	0.000186	0.00329	CcSEcCtD
Oxandrolone—Insomnia—Fenoldopam—hypertension	0.000183	0.00324	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYOD1—hypertension	0.000183	0.0106	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—BRCA1—hypertension	0.00018	0.0105	CbGpPWpGaD
Oxandrolone—Insomnia—Nebivolol—hypertension	0.000179	0.00316	CcSEcCtD
Oxandrolone—Haemoglobin—Amlodipine—hypertension	0.000178	0.00314	CcSEcCtD
Oxandrolone—Blood creatinine increased—Valsartan—hypertension	0.000177	0.00313	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—VDR—hypertension	0.000177	0.0103	CbGpPWpGaD
Oxandrolone—Haemorrhage—Amlodipine—hypertension	0.000177	0.00313	CcSEcCtD
Oxandrolone—Oedema—Prazosin—hypertension	0.000177	0.00313	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR2—hypertension	0.000176	0.0102	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Olmesartan—hypertension	0.000176	0.00311	CcSEcCtD
Oxandrolone—Erectile dysfunction—Propranolol—hypertension	0.000176	0.00311	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—ECE1—hypertension	0.000175	0.0102	CbGpPWpGaD
Oxandrolone—Creatinine increased—Lisinopril—hypertension	0.000172	0.00304	CcSEcCtD
Oxandrolone—Irritability—Clonidine—hypertension	0.000172	0.00304	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—HDAC1—hypertension	0.000171	0.00994	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—SOD1—hypertension	0.000171	0.00993	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Diltiazem—hypertension	0.00017	0.00301	CcSEcCtD
Oxandrolone—Erectile dysfunction—Indapamide—hypertension	0.00017	0.00301	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SMAD1—hypertension	0.000169	0.00981	CbGpPWpGaD
Oxandrolone—Insomnia—Torasemide—hypertension	0.000169	0.00298	CcSEcCtD
Oxandrolone—Erectile dysfunction—Carvedilol—hypertension	0.000169	0.00298	CcSEcCtD
Oxandrolone—Oedema—Bepridil—hypertension	0.000167	0.00295	CcSEcCtD
Oxandrolone—Haemoglobin—Guanabenz—hypertension	0.000167	0.00295	CcSEcCtD
Oxandrolone—Irritability—Enalapril—hypertension	0.000167	0.00295	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SMAD6—hypertension	0.000167	0.0097	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CD82—hypertension	0.000167	0.0097	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Doxazosin—hypertension	0.000167	0.00294	CcSEcCtD
Oxandrolone—Haemorrhage—Guanabenz—hypertension	0.000166	0.00294	CcSEcCtD
Oxandrolone—Blood creatinine increased—Trandolapril—hypertension	0.000165	0.00291	CcSEcCtD
Oxandrolone—Erectile dysfunction—Fosinopril—hypertension	0.000165	0.00291	CcSEcCtD
Oxandrolone—Spironolactone—CYP11B1—hypertension	0.000165	0.0555	CrCbGaD
Oxandrolone—Blood creatinine increased—Enalapril—hypertension	0.000164	0.0029	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nifedipine—hypertension	0.000162	0.00287	CcSEcCtD
Oxandrolone—Blood creatinine increased—Telmisartan—hypertension	0.000162	0.00286	CcSEcCtD
Oxandrolone—Erectile dysfunction—Verapamil—hypertension	0.000162	0.00286	CcSEcCtD
Oxandrolone—Gynaecomastia—Ramipril—hypertension	0.000162	0.00286	CcSEcCtD
Oxandrolone—Insomnia—Prazosin—hypertension	0.00016	0.00283	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—EGR1—hypertension	0.00016	0.0093	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR3C1—hypertension	0.00016	0.00927	CbGpPWpGaD
Oxandrolone—Oedema—Methyldopa—hypertension	0.000159	0.00281	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—APOB—hypertension	0.000158	0.00915	CbGpPWpGaD
Oxandrolone—Stanozolol—AR—hypertension	0.000158	0.0532	CrCbGaD
Oxandrolone—Oedema—Hydralazine—hypertension	0.000156	0.00276	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC9A3—hypertension	0.000156	0.00906	CbGpPWpGaD
Oxandrolone—Fluid retention—Lisinopril—hypertension	0.000156	0.00275	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—HDAC1—hypertension	0.000155	0.00902	CbGpPWpGaD
Oxandrolone—Spironolactone—CYP11B2—hypertension	0.000155	0.0522	CrCbGaD
Oxandrolone—Oedema—Pindolol—hypertension	0.000154	0.00273	CcSEcCtD
Oxandrolone—Blood creatinine increased—Perindopril—hypertension	0.000153	0.0027	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BMPR2—hypertension	0.000153	0.00887	CbGpPWpGaD
Oxandrolone—Oedema—Quinapril—hypertension	0.000152	0.00268	CcSEcCtD
Oxandrolone—Irritability—Furosemide—hypertension	0.000151	0.00267	CcSEcCtD
Oxandrolone—Insomnia—Bepridil—hypertension	0.000151	0.00267	CcSEcCtD
Oxandrolone—Blood creatinine increased—Hydrochlorothiazide—hypertension	0.000151	0.00267	CcSEcCtD
Oxandrolone—Erectile dysfunction—Valsartan—hypertension	0.000151	0.00266	CcSEcCtD
Oxandrolone—Erectile dysfunction—Olmesartan—hypertension	0.00015	0.00265	CcSEcCtD
Oxandrolone—Insomnia—Penbutolol—hypertension	0.00015	0.00264	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—PPARA—hypertension	0.000149	0.00868	CbGpPWpGaD
Oxandrolone—Oedema—Benazepril—hypertension	0.000149	0.00264	CcSEcCtD
Oxandrolone—Oedema—Nadolol—hypertension	0.000149	0.00263	CcSEcCtD
Oxandrolone—Blood creatinine increased—Furosemide—hypertension	0.000149	0.00262	CcSEcCtD
Oxandrolone—Haemoglobin—Carvedilol—hypertension	0.000147	0.0026	CcSEcCtD
Oxandrolone—Haemorrhage—Carvedilol—hypertension	0.000146	0.00259	CcSEcCtD
Oxandrolone—Oedema—Isradipine—hypertension	0.000146	0.00259	CcSEcCtD
Oxandrolone—Oedema—Guanfacine—hypertension	0.000146	0.00258	CcSEcCtD
Oxandrolone—Oedema—Nicardipine—hypertension	0.000145	0.00257	CcSEcCtD
Oxandrolone—Haemoglobin—Fosinopril—hypertension	0.000144	0.00254	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—FOS—hypertension	0.000144	0.00834	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Clonidine—hypertension	0.000144	0.00253	CcSEcCtD
Oxandrolone—Blood creatinine increased—Losartan—hypertension	0.000143	0.00253	CcSEcCtD
Oxandrolone—Haemorrhage—Fosinopril—hypertension	0.000143	0.00253	CcSEcCtD
Oxandrolone—Haemoglobin—Nifedipine—hypertension	0.000142	0.00251	CcSEcCtD
Oxandrolone—Insomnia—Amiloride—hypertension	0.000141	0.0025	CcSEcCtD
Oxandrolone—Haemorrhage—Nifedipine—hypertension	0.000141	0.00249	CcSEcCtD
Oxandrolone—Oedema—Esmolol—hypertension	0.00014	0.00248	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—VDR—hypertension	0.00014	0.00813	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Trandolapril—hypertension	0.00014	0.00247	CcSEcCtD
Oxandrolone—Insomnia—Pindolol—hypertension	0.00014	0.00246	CcSEcCtD
Oxandrolone—Erectile dysfunction—Enalapril—hypertension	0.000139	0.00246	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—BRCA1—hypertension	0.000139	0.00806	CbGpPWpGaD
Oxandrolone—Oedema—Terazosin—hypertension	0.000138	0.00244	CcSEcCtD
Oxandrolone—Erectile dysfunction—Telmisartan—hypertension	0.000138	0.00243	CcSEcCtD
Oxandrolone—Insomnia—Quinapril—hypertension	0.000137	0.00242	CcSEcCtD
Oxandrolone—Insomnia—Benazepril—hypertension	0.000135	0.00238	CcSEcCtD
Oxandrolone—Oedema—Acebutolol—hypertension	0.000135	0.00238	CcSEcCtD
Oxandrolone—AR—cardiac ventricle—hypertension	0.000135	0.121	CbGeAlD
Oxandrolone—Insomnia—Nadolol—hypertension	0.000135	0.00238	CcSEcCtD
Oxandrolone—Oedema—Labetalol—hypertension	0.000134	0.00236	CcSEcCtD
Oxandrolone—Erectile dysfunction—Captopril—hypertension	0.000134	0.00236	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—TPH1—hypertension	0.000133	0.0077	CbGpPWpGaD
Oxandrolone—Insomnia—Isradipine—hypertension	0.000132	0.00234	CcSEcCtD
Oxandrolone—Insomnia—Guanfacine—hypertension	0.000132	0.00233	CcSEcCtD
Oxandrolone—Haemoglobin—Valsartan—hypertension	0.000132	0.00232	CcSEcCtD
Oxandrolone—Insomnia—Nicardipine—hypertension	0.000131	0.00232	CcSEcCtD
Oxandrolone—Haemorrhage—Valsartan—hypertension	0.000131	0.00231	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—VAV3—hypertension	0.00013	0.00757	CbGpPWpGaD
Oxandrolone—Insomnia—Metolazone—hypertension	0.00013	0.0023	CcSEcCtD
Oxandrolone—Insomnia—Felodipine—hypertension	0.00013	0.0023	CcSEcCtD
Oxandrolone—Erectile dysfunction—Perindopril—hypertension	0.00013	0.00229	CcSEcCtD
Oxandrolone—Erectile dysfunction—Hydrochlorothiazide—hypertension	0.000128	0.00227	CcSEcCtD
Oxandrolone—AR—myocardium—hypertension	0.000127	0.114	CbGeAlD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C1—hypertension	0.000126	0.00732	CbGpPWpGaD
Oxandrolone—Oedema—Nisoldipine—hypertension	0.000126	0.00222	CcSEcCtD
Oxandrolone—Oedema—Amlodipine—hypertension	0.000126	0.00222	CcSEcCtD
Oxandrolone—Insomnia—Terazosin—hypertension	0.000125	0.00221	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3R1—hypertension	0.000125	0.00726	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Betaxolol—hypertension	0.000125	0.00221	CcSEcCtD
Oxandrolone—Trilostane—ESR2—hypertension	0.000124	0.0418	CrCbGaD
Oxandrolone—AR—Nuclear Receptors—PPARG—hypertension	0.000124	0.00718	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Ramipril—hypertension	0.000123	0.00217	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—HIF1A—hypertension	0.000123	0.00712	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—NR3C1—hypertension	0.000122	0.0071	CbGpPWpGaD
Oxandrolone—Insomnia—Acebutolol—hypertension	0.000122	0.00216	CcSEcCtD
Oxandrolone—Erectile dysfunction—Losartan—hypertension	0.000122	0.00215	CcSEcCtD
Oxandrolone—Oedema—Guanabenz—hypertension	0.000118	0.00209	CcSEcCtD
Oxandrolone—Oedema—Metoprolol—hypertension	0.000118	0.00209	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARA—hypertension	0.000118	0.00686	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—KDR—hypertension	0.000117	0.00681	CbGpPWpGaD
Oxandrolone—Insomnia—Eprosartan—hypertension	0.000117	0.00207	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—HADHA—hypertension	0.000115	0.0067	CbGpPWpGaD
Oxandrolone—Insomnia—Amlodipine—hypertension	0.000114	0.00201	CcSEcCtD
Oxandrolone—Insomnia—Nisoldipine—hypertension	0.000114	0.00201	CcSEcCtD
Oxandrolone—Irritability—Lisinopril—hypertension	0.000114	0.00201	CcSEcCtD
Oxandrolone—Haemoglobin—Perindopril—hypertension	0.000113	0.002	CcSEcCtD
Oxandrolone—Haemorrhage—Perindopril—hypertension	0.000113	0.00199	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—AQP4—hypertension	0.000113	0.00655	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—hypertension	0.000112	0.00649	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Lisinopril—hypertension	0.000111	0.00197	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC1—hypertension	0.000111	0.00643	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—NOTCH1—hypertension	0.00011	0.00641	CbGpPWpGaD
Oxandrolone—Spironolactone—NR3C2—hypertension	0.00011	0.0371	CrCbGaD
Oxandrolone—AR—FOXA1 transcription factor network—FOS—hypertension	0.000109	0.0063	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—INS—hypertension	0.000108	0.00626	CbGpPWpGaD
Oxandrolone—Insomnia—Metoprolol—hypertension	0.000107	0.00189	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—HSPD1—hypertension	0.000106	0.00616	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AHR—hypertension	0.000106	0.00615	CbGpPWpGaD
Oxandrolone—Oedema—Diltiazem—hypertension	0.000105	0.00186	CcSEcCtD
Oxandrolone—Oedema—Indapamide—hypertension	0.000105	0.00186	CcSEcCtD
Oxandrolone—Erectile dysfunction—Ramipril—hypertension	0.000104	0.00184	CcSEcCtD
Oxandrolone—Oedema—Carvedilol—hypertension	0.000104	0.00184	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—INHBA—hypertension	0.000103	0.00599	CbGpPWpGaD
Oxandrolone—Oedema—Doxazosin—hypertension	0.000103	0.00182	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—HDAC1—hypertension	0.000103	0.00596	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—BRCA1—hypertension	0.000103	0.00596	CbGpPWpGaD
Oxandrolone—Danazol—CCL2—hypertension	0.000102	0.0345	CrCbGaD
Oxandrolone—Erectile dysfunction—Timolol—hypertension	0.000102	0.0018	CcSEcCtD
Oxandrolone—Oedema—Fosinopril—hypertension	0.000102	0.0018	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—TACR1—hypertension	0.000101	0.00584	CbGpPWpGaD
Oxandrolone—Oedema—Nifedipine—hypertension	0.0001	0.00177	CcSEcCtD
Oxandrolone—Oedema—Verapamil—hypertension	9.99e-05	0.00176	CcSEcCtD
Oxandrolone—Insomnia—Propranolol—hypertension	9.82e-05	0.00173	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—hypertension	9.76e-05	0.00567	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—hypertension	9.67e-05	0.00562	CbGpPWpGaD
Oxandrolone—Insomnia—Indapamide—hypertension	9.5e-05	0.00168	CcSEcCtD
Oxandrolone—Insomnia—Diltiazem—hypertension	9.5e-05	0.00168	CcSEcCtD
Oxandrolone—Testosterone Propionate—CYP17A1—hypertension	9.47e-05	0.032	CrCbGaD
Oxandrolone—Erectile dysfunction—Lisinopril—hypertension	9.47e-05	0.00167	CcSEcCtD
Oxandrolone—Drostanolone—AR—hypertension	9.44e-05	0.0319	CrCbGaD
Oxandrolone—Insomnia—Carvedilol—hypertension	9.41e-05	0.00166	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hypertension	9.41e-05	0.00547	CbGpPWpGaD
Oxandrolone—Insomnia—Doxazosin—hypertension	9.31e-05	0.00164	CcSEcCtD
Oxandrolone—Oedema—Valsartan—hypertension	9.3e-05	0.00164	CcSEcCtD
Oxandrolone—Oedema—Olmesartan—hypertension	9.25e-05	0.00163	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—hypertension	9.25e-05	0.00537	CbGpPWpGaD
Oxandrolone—Insomnia—Fosinopril—hypertension	9.19e-05	0.00162	CcSEcCtD
Oxandrolone—AR—adrenal cortex—hypertension	9.15e-05	0.0824	CbGeAlD
Oxandrolone—Insomnia—Eplerenone—hypertension	9.14e-05	0.00161	CcSEcCtD
Oxandrolone—Insomnia—Nifedipine—hypertension	9.07e-05	0.0016	CcSEcCtD
Oxandrolone—Insomnia—Verapamil—hypertension	9.03e-05	0.0016	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—CCNE1—hypertension	8.99e-05	0.00522	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—hypertension	8.93e-05	0.00519	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTK2—hypertension	8.93e-05	0.00519	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL13—hypertension	8.9e-05	0.00517	CbGpPWpGaD
Oxandrolone—Oedema—Clonidine—hypertension	8.86e-05	0.00157	CcSEcCtD
Oxandrolone—AR—heart—hypertension	8.85e-05	0.0797	CbGeAlD
Oxandrolone—AR—smooth muscle tissue—hypertension	8.78e-05	0.079	CbGeAlD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TGFBR1—hypertension	8.77e-05	0.0051	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—hypertension	8.71e-05	0.00506	CbGpPWpGaD
Oxandrolone—Oedema—Trandolapril—hypertension	8.64e-05	0.00153	CcSEcCtD
Oxandrolone—Oedema—Enalapril—hypertension	8.61e-05	0.00152	CcSEcCtD
Oxandrolone—AR—decidua—hypertension	8.61e-05	0.0775	CbGeAlD
Oxandrolone—Oedema—Telmisartan—hypertension	8.49e-05	0.0015	CcSEcCtD
Oxandrolone—Insomnia—Valsartan—hypertension	8.41e-05	0.00149	CcSEcCtD
Oxandrolone—Insomnia—Olmesartan—hypertension	8.37e-05	0.00148	CcSEcCtD
Oxandrolone—AR—cardiovascular system—hypertension	8.35e-05	0.0752	CbGeAlD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ANXA1—hypertension	8.25e-05	0.00479	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TAC1—hypertension	8.19e-05	0.00476	CbGpPWpGaD
Oxandrolone—AR—kidney—hypertension	8.17e-05	0.0736	CbGeAlD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CST3—hypertension	8.1e-05	0.0047	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC6A4—hypertension	8.04e-05	0.00467	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—HMGCR—hypertension	8.02e-05	0.00466	CbGpPWpGaD
Oxandrolone—Oedema—Perindopril—hypertension	8.02e-05	0.00142	CcSEcCtD
Oxandrolone—Insomnia—Clonidine—hypertension	8.02e-05	0.00142	CcSEcCtD
Oxandrolone—Oedema—Irbesartan—hypertension	7.99e-05	0.00141	CcSEcCtD
Oxandrolone—AR—cortex of kidney—hypertension	7.96e-05	0.0716	CbGeAlD
Oxandrolone—Oedema—Hydrochlorothiazide—hypertension	7.92e-05	0.0014	CcSEcCtD
Oxandrolone—Drostanolone—CYP19A1—hypertension	7.9e-05	0.0267	CrCbGaD
Oxandrolone—Insomnia—Trandolapril—hypertension	7.82e-05	0.00138	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—SST—hypertension	7.82e-05	0.00454	CbGpPWpGaD
Oxandrolone—Insomnia—Enalapril—hypertension	7.79e-05	0.00138	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1RN—hypertension	7.78e-05	0.00452	CbGpPWpGaD
Oxandrolone—Testosterone Propionate—COMT—hypertension	7.72e-05	0.0261	CrCbGaD
Oxandrolone—Oedema—Betaxolol—hypertension	7.72e-05	0.00136	CcSEcCtD
Oxandrolone—Insomnia—Telmisartan—hypertension	7.68e-05	0.00136	CcSEcCtD
Oxandrolone—AR—cardiac atrium—hypertension	7.57e-05	0.0681	CbGeAlD
Oxandrolone—Oedema—Losartan—hypertension	7.52e-05	0.00133	CcSEcCtD
Oxandrolone—Insomnia—Captopril—hypertension	7.47e-05	0.00132	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFBR1—hypertension	7.27e-05	0.00422	CbGpPWpGaD
Oxandrolone—Insomnia—Perindopril—hypertension	7.25e-05	0.00128	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—ESR2—hypertension	7.21e-05	0.00419	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—EP300—hypertension	7.19e-05	0.00418	CbGpPWpGaD
Oxandrolone—Insomnia—Hydrochlorothiazide—hypertension	7.17e-05	0.00127	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—TH—hypertension	7.16e-05	0.00416	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—hypertension	7.12e-05	0.00413	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CAV1—hypertension	7.11e-05	0.00413	CbGpPWpGaD
Oxandrolone—Insomnia—Betaxolol—hypertension	6.98e-05	0.00123	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ANXA1—hypertension	6.83e-05	0.00397	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—EP300—hypertension	6.82e-05	0.00396	CbGpPWpGaD
Oxandrolone—Insomnia—Losartan—hypertension	6.8e-05	0.0012	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—NR3C2—hypertension	6.76e-05	0.00393	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EGR1—hypertension	6.75e-05	0.00392	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—STK11—hypertension	6.72e-05	0.00391	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRCA1—hypertension	6.72e-05	0.00391	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CYP19A1—hypertension	6.72e-05	0.00391	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—HDAC1—hypertension	6.72e-05	0.00391	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—hypertension	6.66e-05	0.00387	CbGpPWpGaD
Oxandrolone—AR—adrenal gland—hypertension	6.61e-05	0.0595	CbGeAlD
Oxandrolone—AR—SIDS Susceptibility Pathways—HDAC1—hypertension	6.55e-05	0.00381	CbGpPWpGaD
Oxandrolone—Oedema—Ramipril—hypertension	6.45e-05	0.00114	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—GJA1—hypertension	6.42e-05	0.00373	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MAPK8—hypertension	6.35e-05	0.00369	CbGpPWpGaD
Oxandrolone—Oedema—Timolol—hypertension	6.3e-05	0.00111	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—hypertension	6.25e-05	0.00363	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TGFBR2—hypertension	6.22e-05	0.00361	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EP300—hypertension	6.19e-05	0.0036	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR2—hypertension	6.14e-05	0.00356	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—hypertension	6.07e-05	0.00353	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—hypertension	6.02e-05	0.0035	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GNB3—hypertension	6e-05	0.00349	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—PPARGC1A—hypertension	6e-05	0.00349	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C2—hypertension	5.94e-05	0.0201	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—AVP—hypertension	5.92e-05	0.00344	CbGpPWpGaD
Oxandrolone—Oedema—Lisinopril—hypertension	5.85e-05	0.00103	CcSEcCtD
Oxandrolone—Insomnia—Ramipril—hypertension	5.83e-05	0.00103	CcSEcCtD
Oxandrolone—Testosterone Propionate—AR—hypertension	5.76e-05	0.0194	CrCbGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—hypertension	5.75e-05	0.00334	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGR1—hypertension	5.74e-05	0.00333	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hypertension	5.73e-05	0.00333	CbGpPWpGaD
Oxandrolone—AR—endocrine gland—hypertension	5.73e-05	0.0516	CbGeAlD
Oxandrolone—Insomnia—Timolol—hypertension	5.7e-05	0.00101	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—NEDD4L—hypertension	5.6e-05	0.00325	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STK11—hypertension	5.57e-05	0.00324	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BRCA1—hypertension	5.57e-05	0.00324	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL10—hypertension	5.57e-05	0.00324	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RHOA—hypertension	5.43e-05	0.00316	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PIK3R1—hypertension	5.38e-05	0.00312	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—AR—hypertension	5.33e-05	0.018	CrCbGaD
Oxandrolone—Insomnia—Lisinopril—hypertension	5.29e-05	0.000934	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—YWHAZ—hypertension	5.24e-05	0.00304	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PDGFA—hypertension	5.23e-05	0.00304	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—hypertension	5.2e-05	0.00302	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NGF—hypertension	5.18e-05	0.00301	CbGpPWpGaD
Oxandrolone—AR—central nervous system—hypertension	5.16e-05	0.0465	CbGeAlD
Oxandrolone—AR—SIDS Susceptibility Pathways—NR3C1—hypertension	5.15e-05	0.00299	CbGpPWpGaD
Oxandrolone—Danazol—AR—hypertension	5.1e-05	0.0172	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RELA—hypertension	5.06e-05	0.00294	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HTR2A—hypertension	4.93e-05	0.00286	CbGpPWpGaD
Oxandrolone—Spironolactone—AR—hypertension	4.88e-05	0.0165	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—hypertension	4.88e-05	0.00283	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—GATA4—hypertension	4.87e-05	0.00283	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MMP1—hypertension	4.86e-05	0.00282	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—hypertension	4.7e-05	0.00273	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HIF1A—hypertension	4.69e-05	0.00273	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hypertension	4.64e-05	0.00269	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PRKCA—hypertension	4.49e-05	0.00261	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—hypertension	4.46e-05	0.00259	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—hypertension	4.41e-05	0.00256	CbGpPWpGaD
Oxandrolone—Progesterone—CYP17A1—hypertension	4.35e-05	0.0147	CrCbGaD
Oxandrolone—Methyltestosterone—AR—hypertension	4.31e-05	0.0145	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CDKN1A—hypertension	4.3e-05	0.0025	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—hypertension	4.29e-05	0.00249	CbGpPWpGaD
Oxandrolone—Danazol—CYP19A1—hypertension	4.27e-05	0.0144	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—NPPA—hypertension	4.25e-05	0.00247	CbGpPWpGaD
Oxandrolone—Norethindrone—CYP3A5—hypertension	4.12e-05	0.0139	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EP300—hypertension	4.09e-05	0.00238	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FGFR1—hypertension	4.05e-05	0.00235	CbGpPWpGaD
Oxandrolone—Testosterone—CYP11A1—hypertension	4.04e-05	0.0136	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—hypertension	3.98e-05	0.00231	CbGpPWpGaD
Oxandrolone—Progesterone—ABCC1—hypertension	3.94e-05	0.0133	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—hypertension	3.88e-05	0.00226	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—hypertension	3.84e-05	0.00223	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—NR3C1—hypertension	3.62e-05	0.0122	CrCbGaD
Oxandrolone—Methyltestosterone—CYP19A1—hypertension	3.61e-05	0.0122	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EGFR—hypertension	3.49e-05	0.00203	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BCL2—hypertension	3.39e-05	0.00197	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—hypertension	3.34e-05	0.00194	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—CTGF—hypertension	3.33e-05	0.00194	CbGpPWpGaD
Oxandrolone—Spironolactone—NR3C1—hypertension	3.31e-05	0.0112	CrCbGaD
Oxandrolone—AR—Gene Expression—NR3C2—hypertension	3.26e-05	0.00189	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MTOR—hypertension	3.25e-05	0.00189	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypertension	3.22e-05	0.00187	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR2—hypertension	3.05e-05	0.00177	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CXCL8—hypertension	3.05e-05	0.00177	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—hypertension	2.96e-05	0.00172	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1B—hypertension	2.92e-05	0.0017	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH2—hypertension	2.89e-05	0.00168	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—hypertension	2.81e-05	0.00163	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—hypertension	2.81e-05	0.00163	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—HDAC1—hypertension	2.77e-05	0.00161	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NEDD4L—hypertension	2.7e-05	0.00157	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EP300—hypertension	2.68e-05	0.00156	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—hypertension	2.67e-05	0.00155	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hypertension	2.67e-05	0.00155	CbGpPWpGaD
Oxandrolone—Progesterone—AR—hypertension	2.64e-05	0.00892	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EP300—hypertension	2.61e-05	0.00152	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—hypertension	2.54e-05	0.00147	CbGpPWpGaD
Oxandrolone—Testosterone—AR—hypertension	2.5e-05	0.00843	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—hypertension	2.47e-05	0.00144	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—hypertension	2.47e-05	0.00144	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—VDR—hypertension	2.42e-05	0.00141	CbGpPWpGaD
Oxandrolone—Progesterone—CYP3A5—hypertension	2.4e-05	0.0081	CrCbGaD
Oxandrolone—AR—Gene Expression—GATA4—hypertension	2.35e-05	0.00136	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—hypertension	2.34e-05	0.00136	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hypertension	2.33e-05	0.00136	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—hypertension	2.33e-05	0.00135	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EGFR—hypertension	2.28e-05	0.00133	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hypertension	2.28e-05	0.00132	CbGpPWpGaD
Oxandrolone—Testosterone—CYP3A5—hypertension	2.27e-05	0.00766	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EP300—hypertension	2.22e-05	0.00129	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR3C1—hypertension	2.18e-05	0.00126	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—hypertension	2.16e-05	0.00125	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—hypertension	2.12e-05	0.00123	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hypertension	2.1e-05	0.00122	CbGpPWpGaD
Oxandrolone—Testosterone—CYP19A1—hypertension	2.09e-05	0.00706	CrCbGaD
Oxandrolone—AR—Gene Expression—NPPA—hypertension	2.04e-05	0.00119	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARA—hypertension	2.04e-05	0.00119	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—hypertension	1.94e-05	0.00112	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hypertension	1.93e-05	0.00112	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—hypertension	1.92e-05	0.00111	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—hypertension	1.89e-05	0.0011	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—hypertension	1.8e-05	0.00105	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C1—hypertension	1.79e-05	0.00605	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH1—hypertension	1.79e-05	0.00104	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6—hypertension	1.71e-05	0.000994	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—hypertension	1.69e-05	0.00098	CbGpPWpGaD
Oxandrolone—Progesterone—CYP1A1—hypertension	1.63e-05	0.00549	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—hypertension	1.62e-05	0.000941	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CTGF—hypertension	1.6e-05	0.000932	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—hypertension	1.59e-05	0.000923	CbGpPWpGaD
Oxandrolone—Norethindrone—ALB—hypertension	1.56e-05	0.00525	CrCbGaD
Oxandrolone—Testosterone—CYP1A1—hypertension	1.54e-05	0.00519	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—SERPINE1—hypertension	1.52e-05	0.000882	CbGpPWpGaD
Oxandrolone—Methyltestosterone—ALB—hypertension	1.48e-05	0.00499	CrCbGaD
Oxandrolone—AR—Gene Expression—ESR2—hypertension	1.47e-05	0.000852	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH2—hypertension	1.39e-05	0.000807	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	1.34e-05	0.00078	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HDAC1—hypertension	1.33e-05	0.000774	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—VDR—hypertension	1.16e-05	0.000677	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—H2AFX—hypertension	1.1e-05	0.000641	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PRKCA—hypertension	1.07e-05	0.000624	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—YWHAZ—hypertension	1.07e-05	0.000619	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR3C1—hypertension	1.05e-05	0.000609	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PRKCD—hypertension	1.02e-05	0.000595	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARA—hypertension	9.82e-06	0.000571	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—hypertension	9.61e-06	0.000558	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH1—hypertension	8.6e-06	0.0005	CbGpPWpGaD
Oxandrolone—Testosterone—ALB—hypertension	8.57e-06	0.00289	CrCbGaD
Oxandrolone—AR—Gene Expression—PPARG—hypertension	8.12e-06	0.000472	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SERPINE1—hypertension	7.31e-06	0.000425	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—hypertension	4.63e-06	0.000269	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—hypertension	3.21e-06	0.000186	CbGpPWpGaD
